Who we are
Healogics is the nation’s leading provider of advanced wound care. Wound care treatment is very important and more common than most people realize. In fact, 1 in 4 families has a family member with a chronic wound. The impact on people and their loved ones is astounding, as a wound left untreated can lead to diminished quality of life and possible amputation of the affected limb. Approximately 30 percent of untreated chronic wounds result in amputation, and five-years post-amputation the mortality rate is approximately 75 percent.
Fortunately, there is hope for people who suffer from chronic wounds. Every team member within the Healogics network of nearly 600 Wound Care Centers® dedicates themselves every day to healing and caring for people with hard-to-heal wounds. The expertise of our Wound Care Centers’ specialty-trained wound care physicians allows Centers to treat a variety of chronic wounds.
We have been treating patients with chronic wounds for over 20 years, from over 600 hospital-based wound care centers across the country. Today, Healogics treats over 300,000 wound care patients a year and has healed nearly 4M wounds.
If you’re one of them, we can help.
Healogics has invested in advanced wound care treatment, technology and research. That means our patients heal faster than those who receive only generalized wound care.
Wound Science Initiative
The Healogics Wound Science Initiative is our commitment to use research to advance the science of wound care and continually improve treatment. Through our database of more than five million wounds and our partnerships with academic and scientific leaders, Healogics has become the foremost expert in evidence-based wound care, resulting in better wound care outcomes for our patients and partners.
Q&A about PAD with Carolyn Shinn, RN, BSN, CWS, Vice President, Clinical and Quality Process Excellence
Peripheral artery disease increases the risks of non-healing wounds that can lead to amputations. Carolyn Shinn, RN, BSN, CWS, discusses symptoms and treatments.Learn More
Learn the Symptoms and Risk Factors for Peripheral Artery Disease (PAD)
Peripheral Artery Disease (PAD) affects nearly 10 million people in the U. S., especially those over 65, and increases the risks of chronic wounds and amputations.Learn More
Healogics Raises Awareness of Peripheral Artery Disease (PAD) to Help Reduce Amputations
PAD affects nearly 10 million Americans and is a contributing factor in up to 30% of non-healing wounds on the lower leg.Learn More
The Joint Commission’s Gold Seal of Approval®
The Joint Commission’s Gold Seal of Approval is granted to healthcare companies that meet their disease-specific certification requirements. Currently, Healogics is the only wound management company that carries this designation. Reaccreditation is required every two years and this is the twelfth year that we have held a disease-specific certification. This accomplishment is just another example of delivering an Exceptional Experience for our patients.
“Behind the Gold Seal of Approval® is a healthcare organization committed to quality. Seeking accreditation is voluntary and shows a commitment to ensuring a safe and effective environment for serving patients.”